Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - StemGen, Inc. | exhibit99_1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): January 25, 2010
AMASYS
Corporation
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
0-21555
|
54-1812385
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File No.)
|
(I.R.S.
Employer Identification No.)
|
625
N. Washington Street, Suite 301, Alexandria, Virginia
|
22314
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (703) 797-8111
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
1.01
|
Entry
into a Material Definitive
Agreement
|
AMASYS
Corporation (“AMASYS” or the “Company”) received an infusion of $5,000 in order
to continue its operations in the near-term. The Company executed a $5,000 note
with C.W. Gilluly, its Chairman and Chief Executive Officer, pursuant to which
C.W. Gilluly advanced the Company $5,000 at a rate of 12% per
annum.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits.
Exhibit
No. Description
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
AMASYS
CORPORATION
Date:
January 29, 2010
|
By:
|
/s/
C.W. Gilluly, Ed.D.
|
|
Name:
C.W. Gilluly, Ed.D.
|
|||
Title:
President and Chief Executive Officer
|
|||